While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...

Google DeepMind by Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) and BioNTech (NASDAQ:BNTX) are collaborating to develop AI lab ...

UBS analyst Eliana Merle maintained a Hold rating on BioNTech SE (BNTX – Research Report) today and set a price target of $131.00. The ...

Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipelineHighlights InstaDeep’s new near ...

BioNTech (NASDAQ:BNTX – Get Free Report) was upgraded by investment analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a report issued on Tuesday ...

10.3% of Ocugen shares are held by institutional investors. Comparatively, 15.5% of BioNTech shares are held by institutional investors. 4.3% of Ocugen shares are held by company insiders.

On Wednesday, TD Cowen maintained its Hold rating on BioNTech (NASDAQ:BNTX), with a consistent price target of $85.00. The firm's stance comes after a detailed review of the company's advancements in ...

Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that Health Canada has authorized the KP.2 ...

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were rockstars on the ... Of course, there is also Pfizer's decision to team up with BioNTech to develop a COVID-19 vaccine. This all happened as ...

LONDON, United Kingdom, October 1, 2024 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company&CloseCurlyDoubleQuote ...

On Wednesday, TD Cowen maintained its Hold rating on BioNTech (NASDAQ:BNTX), with a consistent price target of $85.00. The firm's stance comes after a detailed review of the company's advancements ...

Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipeline Highlights InstaDeep’s new near exascale supercomputer, Kyber, with the aim of ...